Latest Quarter
2025-12-31
Elevance Health Inc (0HG8.L)
Revenue
$49.7B
Net Income
$547M
Operating Margin
1.2%
Free Cash Flow
$3.2B
Debt / Assets
63.8%
Values are in USD and rounded to the nearest whole number unless noted.
Swipe horizontally to view all columns.
| Income Statement (Quarterly) | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | 49,747,000,000 | 50,711,000,000 | 49,776,000,000 | 48,891,000,000 |
| Cost of Revenue | 38,065,000,000 | 38,140,000,000 | 36,706,000,000 | 35,312,000,000 |
| Gross Profit | 11,682,000,000 | 12,571,000,000 | 13,070,000,000 | 13,579,000,000 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 0 | 0 | 0 | 0 |
| Operating Expenses | 11,101,000,000 | 10,814,000,000 | 10,437,000,000 | 10,438,000,000 |
| Operating Income | 581,000,000 | 1,757,000,000 | 2,633,000,000 | 3,141,000,000 |
| Interest Expense | 366,000,000 | 351,000,000 | 341,000,000 | 344,000,000 |
| Income Before Tax | 215,000,000 | 1,406,000,000 | 2,292,000,000 | 2,797,000,000 |
| Income Tax Expense | -331,000,000 | 219,000,000 | 548,000,000 | 613,000,000 |
| Net Income | 547,000,000 | 1,189,000,000 | 1,743,000,000 | 2,183,000,000 |
| Per Share | ||||
| EPS | 2.47 | 5.32 | 7.72 | 9.64 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Statement (Annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | 199,125,000,000 | 176,810,000,000 | 171,340,000,000 | 156,595,000,000 |
| Cost of Revenue | 148,223,000,000 | 0 | 124,330,000,000 | -4,000,000 |
| Gross Profit | 50,902,000,000 | 176,810,000,000 | 47,010,000,000 | 156,599,000,000 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 0 | 0 | 0 | 30,682,000,000 |
| Operating Expenses | 42,790,000,000 | 168,906,000,000 | 38,265,000,000 | 31,502,000,000 |
| Operating Income | 8,112,000,000 | 7,904,000,000 | 8,745,000,000 | 8,663,000,000 |
| Interest Expense | 1,402,000,000 | 1,185,000,000 | 1,030,000,000 | 851,000,000 |
| Income Before Tax | 6,710,000,000 | 7,904,000,000 | 7,715,000,000 | 7,600,000,000 |
| Income Tax Expense | 1,049,000,000 | 1,933,000,000 | 1,724,000,000 | 1,712,000,000 |
| Net Income | 5,662,000,000 | 5,980,000,000 | 5,987,000,000 | 5,894,000,000 |
| Per Share | ||||
| EPS | 25.18 | 25.81 | 25.69 | 24.56 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet (Quarterly) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Cash and Cash Equivalents | 9,491,000,000 | 8,288,000,000 | 6,526,000,000 | 7,387,000,000 |
| Short Term Investments | 0 | 25,201,000,000 | 29,614,000,000 | 26,905,000,000 |
| Net Receivables | 21,542,000,000 | 19,071,000,000 | 17,865,000,000 | 0 |
| Inventory | 0 | 0 | 0 | 0 |
| Total Current Assets | 63,001,000,000 | 0 | 54,005,000,000 | 55,617,000,000 |
| Property Plant Equipment | 4,679,000,000 | 4,652,000,000 | 4,359,000,000 | 4,920,000,000 |
| Goodwill and Intangibles | 50,744,000,000 | 40,371,000,000 | 35,590,000,000 | 34,698,000,000 |
| Total Assets | 121,494,000,000 | 116,889,000,000 | 108,928,000,000 | 102,755,000,000 |
| Liabilities | ||||
| Account Payables | 17,084,000,000 | 22,673,000,000 | 23,021,000,000 | 5,607,000,000 |
| Short Term Debt | 1,249,000,000 | 2,014,000,000 | 1,874,000,000 | 1,946,000,000 |
| Total Current Liabilities | 41,035,000,000 | 0 | 26,297,000,000 | 39,696,000,000 |
| Long Term Debt | 30,797,000,000 | 29,218,000,000 | 23,246,000,000 | 22,349,000,000 |
| Total Liabilities | 77,468,000,000 | 75,463,000,000 | 69,523,000,000 | 66,425,000,000 |
| Shareholders Equity | ||||
| Retained Earnings | 35,393,000,000 | 33,549,000,000 | 31,749,000,000 | 29,647,000,000 |
| Total Shareholders Equity | 43,882,000,000 | 41,315,000,000 | 39,306,000,000 | 36,243,000,000 |
| Balance Sheet (Annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Cash and Cash Equivalents | 9,491,000,000 | 8,288,000,000 | 6,526,000,000 | 7,387,000,000 |
| Short Term Investments | 0 | 25,201,000,000 | 29,614,000,000 | 26,905,000,000 |
| Net Receivables | 21,542,000,000 | 19,071,000,000 | 17,865,000,000 | 0 |
| Inventory | 0 | 0 | 0 | 0 |
| Total Current Assets | 63,001,000,000 | 0 | 54,005,000,000 | 55,617,000,000 |
| Property Plant Equipment | 4,679,000,000 | 4,652,000,000 | 4,359,000,000 | 4,920,000,000 |
| Goodwill and Intangibles | 50,744,000,000 | 40,371,000,000 | 35,590,000,000 | 34,698,000,000 |
| Total Assets | 121,494,000,000 | 116,889,000,000 | 108,928,000,000 | 102,755,000,000 |
| Liabilities | ||||
| Account Payables | 17,084,000,000 | 22,673,000,000 | 23,021,000,000 | 5,607,000,000 |
| Short Term Debt | 1,249,000,000 | 2,014,000,000 | 1,874,000,000 | 1,946,000,000 |
| Total Current Liabilities | 41,035,000,000 | 0 | 26,297,000,000 | 39,696,000,000 |
| Long Term Debt | 30,797,000,000 | 29,218,000,000 | 23,246,000,000 | 22,349,000,000 |
| Total Liabilities | 77,468,000,000 | 75,463,000,000 | 69,523,000,000 | 66,425,000,000 |
| Shareholders Equity | ||||
| Retained Earnings | 35,393,000,000 | 33,549,000,000 | 31,749,000,000 | 29,647,000,000 |
| Total Shareholders Equity | 43,882,000,000 | 41,315,000,000 | 39,306,000,000 | 36,243,000,000 |
| Cash Flow Statement (Quarterly) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | 5,661,000,000 | 5,971,000,000 | 5,987,000,000 | 5,894,000,000 |
| Depreciation & Amortization | 1,546,000,000 | 1,393,000,000 | 1,745,000,000 | 1,675,000,000 |
| Stock Based Compensation | 276,000,000 | 191,000,000 | 289,000,000 | 264,000,000 |
| Change in Working Capital | -3,680,000,000 | -1,719,000,000 | -535,000,000 | 423,000,000 |
| Operating Cash Flow | 4,290,000,000 | 5,808,000,000 | 8,061,000,000 | 8,399,000,000 |
| Investing Activities | ||||
| Capital Expenditure | -1,116,000,000 | -1,256,000,000 | -1,296,000,000 | -1,152,000,000 |
| Investments | -1,116,000,000 | -1,256,000,000 | -1,296,000,000 | -1,152,000,000 |
| Investing Cash Flow | -1,344,000,000 | -5,167,000,000 | -5,572,000,000 | -4,560,000,000 |
| Financing Activities | ||||
| Debt Repayment | 629,000,000 | 5,562,000,000 | 665,000,000 | -1,795,000,000 |
| Common Stock Issued/Repurchased | -2,605,000,000 | -2,900,000,000 | -2,676,000,000 | -2,134,000,000 |
| Dividends Paid | -1,529,000,000 | -1,508,000,000 | -1,395,000,000 | -1,229,000,000 |
| Financing Cash Flow | -1,738,000,000 | 1,193,000,000 | -3,349,000,000 | -1,318,000,000 |
| Summary | ||||
| Free Cash Flow | 3,174,000,000 | 4,552,000,000 | 6,765,000,000 | 7,247,000,000 |
| Net Change in Cash | 1,203,000,000 | 1,762,000,000 | -861,000,000 | 2,507,000,000 |
| Cash Flow Statement (Annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | 5,661,000,000 | 5,971,000,000 | 5,987,000,000 | 5,894,000,000 |
| Depreciation & Amortization | 1,546,000,000 | 1,393,000,000 | 1,745,000,000 | 1,675,000,000 |
| Stock Based Compensation | 276,000,000 | 191,000,000 | 289,000,000 | 264,000,000 |
| Change in Working Capital | -3,680,000,000 | -1,719,000,000 | -535,000,000 | 423,000,000 |
| Operating Cash Flow | 4,290,000,000 | 5,808,000,000 | 8,061,000,000 | 8,399,000,000 |
| Investing Activities | ||||
| Capital Expenditure | -1,116,000,000 | -1,256,000,000 | -1,296,000,000 | -1,152,000,000 |
| Investments | -1,116,000,000 | -1,256,000,000 | -1,296,000,000 | -1,152,000,000 |
| Investing Cash Flow | -1,344,000,000 | -5,167,000,000 | -5,572,000,000 | -4,560,000,000 |
| Financing Activities | ||||
| Debt Repayment | 629,000,000 | 5,562,000,000 | 665,000,000 | -1,795,000,000 |
| Common Stock Issued/Repurchased | -2,605,000,000 | -2,900,000,000 | -2,676,000,000 | -2,134,000,000 |
| Dividends Paid | -1,529,000,000 | -1,508,000,000 | -1,395,000,000 | -1,229,000,000 |
| Financing Cash Flow | -1,738,000,000 | 1,193,000,000 | -3,349,000,000 | -1,318,000,000 |
| Summary | ||||
| Free Cash Flow | 3,174,000,000 | 4,552,000,000 | 6,765,000,000 | 7,247,000,000 |
| Net Change in Cash | 1,203,000,000 | 1,762,000,000 | -861,000,000 | 2,507,000,000 |